306 related articles for article (PubMed ID: 14610867)
21. [Differential diagnosis of kidney diseases].
Brod J
Med Welt; 1979 Feb; 30(7):254-63. PubMed ID: 431396
[No Abstract] [Full Text] [Related]
22. [Selection of antihypertensive agents with view of organ protection].
Tsuchihashi T
Fukuoka Igaku Zasshi; 2002 Dec; 93(12):255-8. PubMed ID: 12713009
[No Abstract] [Full Text] [Related]
23. An issue of dependence: implications from the Aliskiren in the Evaluation of Proteinuria in Diabetes (AVOID) trial.
Riche DM; Minor DS; Holdiness AS; East HE
J Clin Hypertens (Greenwich); 2009 Feb; 11(2):89-93. PubMed ID: 19222674
[No Abstract] [Full Text] [Related]
24. [Subclinical albuminuria, microalbuminuria and proteinuria--accepted cardiovascular risk markers?].
Schmieder RE; Schrader J; Zidek W; Tebbe U; Bramlage P; Paar WD; Böhm M
Dtsch Med Wochenschr; 2006 Nov; 131(47):2665-71. PubMed ID: 17109277
[No Abstract] [Full Text] [Related]
25. Slowing progression along the renal disease continuum.
Kopyt NP
J Am Osteopath Assoc; 2005 Apr; 105(4):207-15. PubMed ID: 15928338
[TBL] [Abstract][Full Text] [Related]
26. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
27. [Microalbuminuria is an early marker for increased morbidity and mortality].
Bramlage P; Wittchen HU; Pittrow D; Dikow R; Kirch W; Lehnert H; Ritz E
Fortschr Med Orig; 2003 Feb; 121 Suppl 1():28-32. PubMed ID: 14732947
[TBL] [Abstract][Full Text] [Related]
28. Importance of blood pressure control in chronic kidney disease.
Ravera M; Re M; Deferrari L; Vettoretti S; Deferrari G
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S98-103. PubMed ID: 16565257
[TBL] [Abstract][Full Text] [Related]
29. Advances in the treatment of diabetic renal disease: focus on losartan.
Rayner B
Curr Med Res Opin; 2004 Mar; 20(3):333-40. PubMed ID: 15025842
[TBL] [Abstract][Full Text] [Related]
30. Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases.
Seeman T; Dusek J; Vondrák K; Flögelová H; Geier P; Janda J
Am J Hypertens; 2004 May; 17(5 Pt 1):415-20. PubMed ID: 15110900
[TBL] [Abstract][Full Text] [Related]
31. [Comrades! There must be some blood order in the field of hypertension!].
Melander A
Lakartidningen; 2005 Apr 4-10; 102(14):1068-70. PubMed ID: 15892478
[No Abstract] [Full Text] [Related]
32. [Diabetic nephropathy. Are the blood pressure values set too low?].
Zidek W
MMW Fortschr Med; 2003 Dec; 145(49):14. PubMed ID: 14963985
[No Abstract] [Full Text] [Related]
33. Maximizing inhibition of the renin-angiotensin system with high doses of converting enzyme inhibitors or angiotensin receptor blockers.
Berl T
Nephrol Dial Transplant; 2008 Aug; 23(8):2443-7. PubMed ID: 18467376
[No Abstract] [Full Text] [Related]
34. [Risk factors to be considered at the beginning of antihypertensive therapy in diabetes mellitus].
Jermendy G
Orv Hetil; 2004 May; 145(18):949-56. PubMed ID: 15188641
[TBL] [Abstract][Full Text] [Related]
35. [Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline].
Renke M; Rutkowski P; Tylicki L; Zietkiewicz M; Larczyński W; Rutkowski B
Przegl Lek; 2008; 65(6):312-4. PubMed ID: 18853664
[TBL] [Abstract][Full Text] [Related]
36. [The role of primary physicians in the early detection and treatment of chronic renal disease: challenges and opportunities].
Cueto-Manzano AM
Rev Invest Clin; 2008; 60(6):517-26. PubMed ID: 19378838
[No Abstract] [Full Text] [Related]
37. Severe hypertension: special problems in the elderly.
Weber MA; Drayer JI
Geriatrics; 1983 Apr; 38(4):40-6, 51-2. PubMed ID: 6339325
[No Abstract] [Full Text] [Related]
38. [IgA nephropathy].
Alamartine E
Rev Prat; 2003 Nov; 53(18):2023-6. PubMed ID: 15008216
[TBL] [Abstract][Full Text] [Related]
39. The CARI guidelines. Prevention of progression of kidney disease.
Harris D; Thomas M; Johnson D; Nicholls K; Gillin A;
Nephrology (Carlton); 2006 Apr; 11 Suppl 1():S2-197. PubMed ID: 16684077
[No Abstract] [Full Text] [Related]
40. [Vascular impact of anti-hypertensive treatment and renal protection].
Mogensen CE
Curr Med Res Opin; 2005; 21 Suppl 5():S23-8. PubMed ID: 16197649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
